Loading stock data…
DNA X, Inc. (SONM)
$5.15-0.73 (-12.41%)
Market ClosedLast close Jun 30
DNA X, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
DNA X, Inc. in the Technology sector is trading at $5.15 with a market capitalization of $7M. The stock is currently near its 52-week low of $2.52, remaining 20.5% below its 200-day moving average. On fundamentals, Piotroski 1/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 15/100 signals elevated caution as multiple indicators diverge.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0↑ | -$44.13M↓ | $16.21M↑ | $11.19M | $0 |
| Gross Profit | — | -$11.02M↓ | $1.82M↑ | $845,000↓ | $8.36M |
| Operating Income | -$3.62M↓ | $4.66M↑ | -$3.98M↑ | -$6.73M↓ | -$870,000 |
| Net Income | $6.34M↑ | -$8.89M↓ | -$4.75M↑ | -$7.47M↓ | $458,000 |
Peer Comparison
AAPLMSFTGOOGL
Fundamentals
DNA X, Inc. provides enterprise 5G solutions in the United States, Canada, Europe, the Middle East, and the Asia Pacific. The company offers ruggedized cell phones for task workers, which include Sonim XP10, Sonim XP5plus, Sonim XP3plus, and Sonim XP...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$7.28M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.93
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
17801.20%
Volume
Today's trading volume
13,920